|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets: | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Deferred offering costs associated with initial public offering | ||||||
| Investments held in Trust Account | ||||||
| Total assets | ||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | ||||||
| Current liabilities: | ||||||
| Accounts payable | ||||||
| Accrued expenses | ||||||
| Note payable - related party | ||||||
| Due to related party | ||||||
| Total current liabilities | ||||||
| Deferred underwriting commissions | ||||||
| Derivative liabilities | ||||||
| Total liabilities | ||||||
| Class A ordinary shares; 34,500,000 shares subject to possible redemption at $10.00 per share redemption value as of September 30, 2021 and December 31, 2020 | ||||||
| Common Class A | ||||||
| Total class A ordinary shares; 34,500,000 shares subject to possible redemption at $10.00 per share redemption value as of September 30, 2021 and December 31, 2020 | ||||||
| Shareholders' Deficit: | ||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020 | ||||||
| Common stock | ||||||
| Common Class A | ||||||
| Ordinary Class B | ||||||
| Additional paid-in capital | ||||||
| Common Class A | ||||||
| Total additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Common Class A | ||||||
| Total accumulated deficit | ||||||
| Total shareholders' deficit | ||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit |
Loading...
